LEXEO THERAPEUTICS INC (LXEO) Stock Cash Flow
NASDAQ:LXEO - Nasdaq - US52886X1072 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -77.21M | -66.39M | -59.28M | -50.62M | -5.15M | |||
| Depreciation Amortization | 628.00K | 577.00K | 270.00K | 10.00K | 0.00 | |||
| Change In Working Capital | 4.96M | 1.48M | 1.79M | 6.04M | 150.00K | |||
| Other non cash items | 8.68M | 4.84M | 2.66M | 390.00K | 1.87M | |||
| OPERATING CASH FLOW | -62.95M | -59.50M | -54.56M | -44.18M | -3.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -536.00K | -165.00K | -900.00K | -190.00K | 0.00 | |||
| INVESTING CASH FLOW | -536.00K | -165.00K | -900.00K | -190.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 3.60M | 3.58M | -160.00K | 0.00 | 2.60M | |||
| Stock Issued/Repurchased | 89.17M | 51.00K | 350.00K | 151.23M | 30.00M | |||
| Other Financing Activity | N/A | 100.17M | 0.00 | -370.00K | -220.00K | |||
| FINANCING CASH FLOW | 192.94M | 103.79M | 190.00K | 150.86M | 32.38M | |||
| CHANGE IN CASH | 129.46M | 44.13M | -55.27M | 106.49M | 29.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -62.95M | -59.50M | -54.56M | -44.18M | -3.13M | |||
| Capital Expenditure | -536.00K | -165.00K | -900.00K | -190.00K | 0.00 | |||
| FREE CASH FLOW | -63.48M | -59.66M | -55.46M | -44.37M | -3.13M | |||
All data in USD